Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Other Non-Current Liabilities (2020 - 2022)

Edesa Biotech's Other Non-Current Liabilities history spans 5 years, with the latest figure at $46536.0 for Q2 2022.

  • For Q2 2022, Other Non-Current Liabilities fell 3.84% year-over-year to $46536.0; the TTM value through Jun 2022 reached $46536.0, down 3.84%, while the annual FY2021 figure was $47202.0, 57.72% up from the prior year.
  • Other Non-Current Liabilities for Q2 2022 was $46536.0 at Edesa Biotech, down from $47970.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $48396.0 in Q2 2021 and bottomed at $29320.0 in Q2 2020.
  • The 3-year median for Other Non-Current Liabilities is $47202.0 (2021), against an average of $43480.4.
  • The largest annual shift saw Other Non-Current Liabilities skyrocketed 65.06% in 2021 before it decreased 3.84% in 2022.
  • A 3-year view of Other Non-Current Liabilities shows it stood at $47082.0 in 2020, then grew by 0.34% to $47244.0 in 2021, then dropped by 1.5% to $46536.0 in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Other Non-Current Liabilities are $46536.0 (Q2 2022), $47970.0 (Q1 2022), and $47244.0 (Q4 2021).